SC 13D

SCHEDULE 13D

Company: Coeptis Therapeutics Holdings, Inc.
Filed: November 7, 2022
Accession Number: 0001213900-22-069745

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →

View Document ↗ View on SEC.gov ↗